MYCOPHENOLATEEffective Shared Care Agreement • February 16th, 2016
Contract Type FiledFebruary 16th, 2016This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of mycophenolate for Connective Tissue Disease can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are not obliged to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.